Skip to search formSkip to main content

WBI-1001

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial.
BACKGROUND There is a need for the development of novel nonsteroidal topical drugs for the treatment of atopic dermatitis (AD… Expand
Is this relevant?
2011
2011
Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.
BACKGROUND There is a need for the development of novel non-steroidal topical drugs for the treatment of psoriasis. OBJECTIVE… Expand
Is this relevant?
2010
2010
Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.
explain unique variance associated with sunbathing intentions and intentions to sun protect. For both analyses, age, sex, skin… Expand
  • figure 1
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE